Efficacy and Safety Study of SyB L-0501 in Combination With Rituximab in Patients With Untreated, Low-grade B Cell Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma

Clinical trial NCT01718691 · COMPLETED

Trial details

NCT number

NCT01718691

Sponsor

SymBio Pharmaceuticals

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2011-11-01

Primary completion

2013-11-01

Enrollment

70

View on ClinicalTrials.gov